Ciprofloxacin Hydrochloride and Hydrocortisone Otic Suspension/Drops — FDA Drug Shortage
The FDA lists a drug shortage record for Ciprofloxacin Hydrochloride and Hydrocortisone Otic Suspension/Drops from Sandoz Inc. with status To Be Discontinued. The shortage was first posted on Oct 30, 2026.
Shortage details
- Status
- To Be Discontinued
- Company
- Sandoz Inc.
- Package NDC
- 66758-087-70
- Presentation
- Cipro, Otic Suspension/Drops, 0.2% base, 1% (NDC 66758-087-70)
- Initial Posting
- Oct 30, 2026